NYSE:DHR

Danaher - DHR Stock Forecast, Price & News

$265.86

+2.91 (+1.11%)

(As of 01/26/2023 12:00 AM ET)

Add

Compare

Today's Range: $260.82
▼
$265.90
50-Day Range: $252.49
▼
$277.00
52-Week Range: $233.71
▼
$303.82

Volume: 3.83 million shs
Average Volume: 3.04 million shs
Market Capitalization: $193.54 billion

P/E Ratio: 27.55
Dividend Yield: 0.38%
Price Target: $310.29

Institutional Ownership

Danaher MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.77 Rating Score
Upside/Downside: 16.7% Upside
$310.29 Price Target
Short Interest: Healthy
0.62% of Float Sold Short
Dividend Strength: Moderate
Based on Four Factors
Sustainability: -1.37
Upright™ Environmental Score
News Sentiment: 0.40
Based on 26 Articles This Week
Insider Trading: Selling Shares
$12.65 M Sold Last Quarter
Proj. Earnings Growth: 10.13%
From $10.37 to $11.42 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.05 out of 5 stars

Multi-Sector Conglomerates Sector

8th out of 15 stocks

Process Control Instruments Industry

6th out of 11 stocks

3.4

Analyst's Opinion

Consensus Rating
Danaher has received a consensus rating of Buy. The company's average rating score is 2.79, and is based on 11 buy ratings, 3 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $310.29, Danaher has a forecasted upside of 16.7% from its current price of $265.86.
Amount of Analyst Coverage
Danaher has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

4.0

Short Interest

Percentage of Shares Shorted
0.62% of the float of Danaher has been sold short.
Short Interest Ratio / Days to Cover
Danaher has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Danaher has recently decreased by 2.63%, indicating that investor sentiment is improving.

2.5

Dividend Strength

Dividend Yield
Danaher has a dividend yield of 0.38%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Danaher has been increasing its dividend for 6 years.
Dividend Coverage
The dividend payout ratio of Danaher is 10.36%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Danaher will have a dividend payout ratio of 8.76% next year. This indicates that Danaher will be able to sustain or increase its dividend.

3.7

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Danaher has received a 47.35% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Prenatal screening services", "Point-of-care tests", "Private genetic testing services", "Non-invasive prenatal testing services", "AI powered medical diagnostic machines", and "Oligonucleotides" products. See details.
Environmental Sustainability
The Environmental Impact score for Danaher is -1.37.

3.0

News and Social Media Coverage

News Sentiment
Danaher has a news sentiment score of 0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Multi-Sector Conglomerates companies.
News Coverage This Week
MarketBeat has tracked 26 news articles for Danaher this week, compared to 8 articles on an average week.
Search Interest
40 people have searched for DHR on MarketBeat in the last 30 days. This is an increase of 186% compared to the previous 30 days.
MarketBeat Follows
23 people have added Danaher to their MarketBeat watchlist in the last 30 days. This is an increase of 10% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Danaher insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $12,646,795.00 in company stock.
Percentage Held by Insiders
11.20% of the stock of Danaher is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
77.26% of the stock of Danaher is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Danaher are expected to grow by 10.13% in the coming year, from $10.37 to $11.42 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Danaher is 27.55, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 134.52.
Price to Earnings Ratio vs. Sector
The P/E ratio of Danaher is 27.55, which means that it is trading at a more expensive P/E ratio than the Multi-Sector Conglomerates sector average P/E ratio of about 6.29.
Price to Earnings Growth Ratio
Danaher has a PEG Ratio of 2.18. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Danaher has a P/B Ratio of 4.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Danaher (NYSE:DHR) Stock

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial, and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment is composed of analytical instruments, reagents, consumables, software, and services that hospitals, physicians' offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.

Receive DHR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Danaher and its competitors with MarketBeat's FREE daily newsletter.

DHR Stock News Headlines

January 16, 2023 | marketbeat.com

General Electric Stock, The Sum of All Parts Strategy is Paying Off (DHR)

Industrial power solutions company General Electric Company (NYSE: GE) stock has climbed over 20% in 2023 as positive sentiment for its restructuring gains

January 26, 2023 | finance.yahoo.com

Danaher Corporation (NYSE:DHR) Q4 2022 Earnings Call Transcript

January 27, 2023 | Porter & Company (Ad)

The Next Big Crisis Is Here

You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.